Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today announced investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf™, for reliable and highly stable droplet generation and processing. Sphere Fluidics will expand operations to meet demand for large-scale commercial supply of its high-performing surfactant for use in a wide range of microfluidic application workflows.

Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant
Sphere Fluidics’ proprietary surfactant, Pico-Surf™ Image credit: Sphere Fluidics

Pico-Surf is a high-quality and animal-origin-free biocompatible surfactant optimized to support the formation of aqueous solution-in-oil picodroplets. Sphere Fluidics aims to increase production of Pico-Surf by three-fold in 2020, whilst maintaining its industry-leading standards, through significant investment of resources in manufacture and quality control processes, and workforce. As part of Sphere Fluidics’ range of specialist chemicals, Pico-Surf is designed to work effectively and flexibly across a broad range of microfluidic systems, including the Company’s proprietary single-cell analysis platforms and applications, such as molecular biology assays, cell secretion assays and cell growth studies.

The unique and patented molecular structure of Pico-Surf stabilizes droplets, and retains and protects their cellular and molecular contents over a wide range of temperatures and biological conditions, helping to ensure high cell viability for improved assay performance. Droplets generated using Pico-Surf show low end point interfacial tension and critical micelle concentration in comparison to other commercially available surfactants. The purity and quality of the surfactant also enables a more efficient droplet sorting process at low voltage. The ready-to-use surfactant is available in large batches or made-to-order with ensured lot-to-lot consistency.

Dr. Marian Rehak, Vice President of Research and Development, Sphere Fluidics, said:

We are enthused by the increased demand for Pico-Surf, and eager to mobilize its production to meet demand. Whilst doing so, we will ensure its very high quality control standards are maintained, meaning researchers can continue rely on Pico-Surf to create droplets that are stable and reproducible.”

Rob Treanor, Director of Operations, Sphere Fluidics, commented:

Sphere Fluidics’ world-leading expertise in picodroplet technology has enabled the development of an ever-growing range of high-performing patented consumables, vital for the successful use of microfluidic systems. All our consumable products have been designed to be platform-agnostic, so they work effectively with a number of microfluidic systems.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sphere Fluidics. (2020, May 13). Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant. News-Medical. Retrieved on April 21, 2024 from https://www.news-medical.net/news/20200213/Sphere-Fluidics-expands-operations-to-meet-demand-for-large-scale-supply-of-Pico-Surf-surfactant.aspx.

  • MLA

    Sphere Fluidics. "Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant". News-Medical. 21 April 2024. <https://www.news-medical.net/news/20200213/Sphere-Fluidics-expands-operations-to-meet-demand-for-large-scale-supply-of-Pico-Surf-surfactant.aspx>.

  • Chicago

    Sphere Fluidics. "Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant". News-Medical. https://www.news-medical.net/news/20200213/Sphere-Fluidics-expands-operations-to-meet-demand-for-large-scale-supply-of-Pico-Surf-surfactant.aspx. (accessed April 21, 2024).

  • Harvard

    Sphere Fluidics. 2020. Sphere Fluidics expands operations to meet demand for large-scale supply of Pico-Surf surfactant. News-Medical, viewed 21 April 2024, https://www.news-medical.net/news/20200213/Sphere-Fluidics-expands-operations-to-meet-demand-for-large-scale-supply-of-Pico-Surf-surfactant.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sphere Fluidics expands Cyto-Mine capabilities to meet cGMP requirements for drug manufacture workflows